Skip To Main Content
Alexa Barad on Muck Rack

Alexa Barad

As seen in: medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexa

Contact Alexa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Leukocyte DNA methylation-based signatures for atherosclerotic cardiovascular disease risk prediction in the Million Veteran Program

|
By Alexa Barad, Dennis Khodasevich, Pik Fang Kho
| medRxiv
P.N. reports research grants from Allelica, Amgen, Apple, Boston Scientific, Cleerly, Genentech/Roche, Ionis, Novartis, and Silence Therapeutics; personal fees from AIRNA, Allelica, Amgen, Apple, AstraZeneca, Bain Capital, Blackstone Life Sciences, Bristol Myers Squibb, Broadview Ventures, Creative Education Concepts, CRISPR Therapeutics, Eli Lilly & Co, Esperion Therapeutics, Foresite Capital, Foresite Labs, Genentech/Roche, GV, HeartFlow, Incyte, Magnet Biomedicine, Merck, Novartis, Novo...
Open in Who Shared Issue with article?

Associations between genetically predicted iron status and cardiovascular disease risk: A Mendelian randomization study

|
By Andrew Clark, Kimberly O'Brien, Eva K Pressman, Alexa Barad
| medRxiv
The authors have declared no competing interest. NA This work was supported by the American Heart Association (23PRE1025636) and the NIH National Institute of Diabetes and Digestive and Kidney Diseases (R01DK122216). The funding sources were not involved in the preparation of the manuscript. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (37) Issue with article?
See all 2 articles